Announcements Trials

Browse Landscape

Phase

Status

Completed 10 Recruiting 3 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1872 Neoplasms 1257 Colorectal Neoplasms 1059 Carcinoma, Non-Small-Cell Lung 1012 Stomach Neoplasms 803 Carcinoma, Hepatocellular 785 Lung Neoplasms 769 Prostatic Neoplasms 697 Pancreatic Neoplasms 577 Rectal Neoplasms 450 Ovarian Neoplasms 406 Neoplasm Metastasis 405 Colonic Neoplasms 405 Uterine Cervical Neoplasms 400 Recurrence 383 Leukemia, Myeloid, Acute 372 Esophageal Neoplasms 363 Multiple Myeloma 340 Lymphoma 335 Head and Neck Neoplasms 330 Melanoma 312 Precursor Cell Lymphoblastic Leukemia-Lymphoma 292 Brain Neoplasms 264 Urinary Bladder Neoplasms 256 Liver Neoplasms 225 Nasopharyngeal Carcinoma 223 Leukemia 218 Lymphoma, Large B-Cell, Diffuse 216 Polycystic Ovary Syndrome 210 Squamous Cell Carcinoma of Head and Neck 205

Interventions

Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Gemcitabine 1 Fluorouracil 1 Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Metastatic Pancreatic Adenocarcinoma × Clear all

NCT01729481 2017-07-19

ML22774

Ludwig-Maximilians - University of Munich

Phase 2 Unknown

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡